Collagenik
Collagenik, licence 80054936: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- ATP ATHLÉTIQUE ET THÉRAPEUTIQUE PHARMA INC. ou ATP ATHLETIC AND THERAPEUTIC PHARMA INC.
- NPN or DIN-HM
- 80054936
- Status
- Inactive licence
- Licence date
- 17 October 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 250.02 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Ascorbate de sodium | 41.67 mg | 250,020 µg |
| Bambusa vulgaris Source : Bambusa vulgaris - shoot | 8.33 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Brown rice flour, Gélatine, L-leucine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 3.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce joint pain associated with osteoarthritis. Helps to produce and repair connective tissue. Helps to form red blood cells. A factor in the maintenance of good health. Helps the body to metabolize fats. Helps the body to metabolize proteins. Helps the development and maintenance of bones. Helps in the development and maintenance of cartilage. Helps in the development and maintenance of teeth. Helps in the development and maintenance of gums. Helps in wound healing.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80054936
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.